A second-grade teacher and grandmother experienced ambiguous symptoms like fatigue, back pain and weight loss. They were signs of advanced pancreatic cancer.

Denmark: A study published in Diabetes Care has revealed that semaglutide improves insulin sensitivity in patients with schizophrenia who have prediabetes and are overweight or obese. The ...

Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the award of an up ...

ARPA-H award supports the development of an oral prodrug using Seaport’s proprietary Glyph™ platform to address dysfunctional ...

Seaport Therapeutics and MIPS awarded up to $15 mn from ARPA-H to advance Seaport’s GlyphCele, the first oral therapeutic designed to restore gut lymphatic function: Boston Thur ...

ARPA-H award supports the development of an oral prodrug, based on the Glyph™ platform initially developed at the Monash Institute of Pharmaceutical ...

The project is being led by the Monash Institute of Pharmaceutical Sciences (MIPS) in partnership with long term collaborator, Seaport Therapeutics, and is being backed by up to AUD$21.5M via the ARPA ...

The first and largest dataset of genomic structure variations specific to childhood cancers was published today by scientists from St. Jude Children's Research Hospital and the National Cancer ...

Often described as the end of reproductive life, menopause doesn’t come easy for women. Medically, it marks the beginning of a new and critical phase in women’s long-term health journey. Apart from ...

Can-Fite BioPharma ( (CANF) ) just unveiled an update.

Discover alcohol-free benefits including better mental health, improved relationships, reduced cardiovascular risk, and greater digestive health.